Skip to content
OpenCapital
Get started

Ashland ASH Life Sciences — Total Assets

Other segment segments

Unallocated And Other
$1.24B+4.6%
Specialty Additives
$988M-27.1%
Personal Care And Household
$714M+1.7%
Intermediates And Solvents
$107M-10.1%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOLife Science — Total Assets
$301.7M-2.1%
Danaher logo
DHRLife Sciences — Identifiable assets
$22.87B—
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Segment assets
$3.49B+15.6%
Innovative Industrial Properties, Inc. logo
IIPRLife Science Portfolio Segment: — Segment Total Assets:
$153.98M—
STERIS logo
STEHealthcare Products and Life Sciences — Total Assets
$7.15B+5.0%
GLW
GLWLife Sciences and Emerging Growth Businesses — Segment assets
$1.42B—

Other financials

Income statement

See full
Revenue$482.0M+0.6%
Gross profit$147.0M0.0%
Operating income$39.0M-23.5%
Net income$16.0M-48.4%
EPS (diluted)$0.34-47.7%

Balance sheet

See full
Cash & equivalents$343.0M+104%
Total debt$1.5B-0.6%
Total equity$1.9B-27.1%
Total assets$4.5B-14.0%

Cash flow

See full
Operating cash flow$50.0M+456%
CapEx$17.0M-19.0%
Free cash flow$33.0M+375%

Valuation

See full
Market cap$2.93B-9.0%
Enterprise value$4.06B-10.6%
P/S1.6×0.0×

Profitability

See full
Gross margin30%-1.7pp
Operating margin-37.3%—
Net margin-40.8%-48.8pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity-33.4%-38.5pp
Debt / equity0.8×+0.2×
Current ratio3.1×+0.7×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Ashland’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ashland's life sciences — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ashland's life sciences — total assets?
Ashland (ASH) reported life sciences — total assets of $1.46B in Q1 2026.
How has Ashland's life sciences — total assets changed year-over-year?
Ashland's life sciences — total assets decreased by 22.4% year-over-year, from $1.88B to $1.46B.
What is the long-term trend for Ashland's life sciences — total assets?
Over 4 years (2021 to 2025), Ashland's life sciences — total assets has grown at a -3.7% compound annual growth rate (CAGR), from $7.82B to $6.72B.
What does life sciences — total assets mean?
This metric represents the total economic resources controlled by the Life Sciences segment, including inventory, property, plant, equipment, and intangible assets. It provides a measure of the scale and capital base required to support the segment's revenue generation. Analyzing this helps evaluate the asset utilization and return on capital employed for the business unit.